Industry Symposium 14

13:30-15:00     Capital Suite 17

Diabetic Nephropathy 2020

Chair: Bruce Hendry, London, UK

What is missing from our understanding of Diabetic Nephropathy Chronic Kidney Disease (DN-CKD)? What do the previous trials tell us?
Bruce Hendry, London, UK
Can we identify the patient at risk of rapid progression?
Adeera Levin, Vancouver, Canada
Can we identify the effect of therapy in Type II diabetic patients with renal impairment?
Dick de Zeeuw, Groningen, The Netherlands

Organised by ABBVIE


back to the timetable